Table 3 Clinical characteristics of participants and risk factors associated with Gram-negative 3rd-generation Cephalosporine/carbapenem-resistant Bacteria (GNARB).
 | GNARB | Univariate analysis |  | ||
---|---|---|---|---|---|
Variable | Positive (n = 18) | Negative (n = 80) | OR | 95% CI | p value |
Male sex, n (%) | 9(50.0) | 29(36.3) | 1.76 | 0.71–4.35 | 0.2967 |
Age ≥ 90 years, n (%) | 4(22.2) | 27(33.8) | 0.56 | 0.17–1.80 | 0.4116 |
OHAT-J score, n(%) | Â | Â | Â | Â | Â |
Lip score = 1 | 3(16.7) | 10(12.5) | 1.40 | 0.34–5.61 | 0.7017 |
Tongue score = 1, 2 | 4(22.2) | 21(26.2) | 0.80 | 0.25–2.63 | 1 |
Gum and mucosa score = 1, 2 | 1(5.6) | 7(8.8) | 0.61 | 0.07–5.30 | 1 |
Saliva score = 1, 2 | (16.7) | 13(16.3) | 1.03 | 0.27-4.00 | 1 |
Natural teeth score = 1, 2 | 4(22.2) | 14(17.5) | 1.35 | 0.40–4.58 | 0.7368 |
Denture score = 1 | 5(27.8) | 10(12.5) | 2.69 | 0.82–8.84 | 0.1430 |
Oral cleanliness score = 1, 2 | 8(44.4) | 27(33.8) | 1.57 | 0.61–4.02 | 0.4230 |
Tooth pain score = 1 | 0(0.0) | 3(3.75) | - | - | 1 |
Total score = 3≥ | 6(33.3) | 21(26.3) | 1.40 | 0.50–3.98 | 0.5666 |
Total score = 8≥ | 1(5.56) | 2(2.50) | 2.29 | 0.20–26.7 | 0.4598 |
Number of remaining teeth, n (%) | Â | Â | Â | Â | Â |
0(edentulous) | 5(27.8) | 18(22.5) | 1.32 | 0.43–4.04 | 0.7587 |
1≥ (With remaining teeth) | 13(72.2) | 62(77.5) | 0.75 | 0.34–1.66 | 0.7587 |
1–9 | 13(72.22) | 62(77.5) | 0.75 | 0.34–1.66 | 0.7587 |
10–19 | 3(16.7) | 19(23.8) | 0.64 | 0.17–2.41 | 0.7556 |
20≥ | 5(27.8) | 30(37.5) | 0.64 | 0.22–1.88 | 0.5882 |
Denture use, n (%) | 11(61.1) | 40(50.0) | 1.57 | 0.68–3.64 | 0.4429 |
FOIS = 1,2,3, n (%) | 2(11.1) | 0(0.0) | - | - | 0.0322 |
Presence of comorbidities, n(%) | Â | Â | Â | Â | Â |
Dementia | 7(38.9) | 39(48.8) | 0.67 | 0.26–1.74 | 0.6023 |
Hypertension | 7(38.9) | 34(42.5) | 0.86 | 0.33–2.25 | 1 |
Cerebrovascular disease | 7(38.9) | 21(26.3) | 1.79 | 0.66–4.84 | 0.3861 |
Cardiovascular disease | 4(22.2) | 20(25.0) | 0.86 | 0.26–2.81 | 1 |
Diabetes | 3(16.7) | 18(22.5) | 0.69 | 0.18–2.60 | 0.7556 |
Fracture | 3(16.7) | 18(22.5) | 0.69 | 0.18–2.60 | 0.7556 |
Hyperlipemia | 1(5.6) | 11(13.8) | 0.37 | 0.04–3.04 | 0.4569 |
Osteoporosis | 2(11.1) | 10(12.5) | 0.76 | 0.15–3.73 | 1 |